The clinical diagnosis of myocarditis is suggested by a preceding viral illness, electrocardiographic changes, changes in heart size on x ray examination, and a supportive rise in viral titres.' Until the advent of endomyocardial biopsy, however, it was not possible to obtain histological confirmation of myocarditis in the acute phase and to study the response of the heart muscle to treatment. 2 The present study reports a 16 month experience of the investigation of 12 patients, presenting with an acute onset of cardiac failure, in whom the diagnosis of myocarditis was confirmed by endomyocardial biopsy. Detailed virological studies were performed to assess the relation of the myocarditis to viral infection. Nine of the 12 patients were treated with Accepted for publication 17 August 1983 immunosuppressive drugs for at least six months, and the results of treatment were assessed by serial haemodynamic, angiographic, and biopsy studies.
Patients and methods
Fifteen patients with a suspected diagnosis of acute viral myocarditis underwent investigation at King Nine patients were treated with immunosuppressive drugs, eight with azathioprine and prednisolone, and one with prednisolone alone. All had histological evidence of myocarditis and three had positive viral serology. Three patients were not treated with immunosuppression at the request of the referring physicians.
Seven of the patients treated with immunosuppressive drugs showed appreciable clinical improvement after two months, with the histological features of healed myocarditis. Two patients, however (one treated with prednisolone alone), had evidence of continuing active myocarditis, and in both the histological picture was associated with the absence of clinical and haemodynamic improvement. Haemodynamic findings for the whole group improved (Fig. 2) 
Discussion
While acute myocarditis has been accepted as a clinical entity for many years,7 its incidence, pathogenesis, and natural history have remained somewhat obscure. With the advent of endomyocardial biopsy, a definitive histological diagnosis of myocarditis is now possible during the acute stage.8 This, combined with virological studies, has allowed more detailed assessment of the condition.
Evidence has accumulated that viruses account for many cases.9 Coxsackie B virus is most commonly implicated, and Grist and Bell10 found that this group of viruses was responsible in up to 40% of cases of myocarditis and pericarditis. In our series, histologically proved myocarditis was associated with a possible virus infection in half of the patients examined. Coxsackie B virus was implicated in five patients by the presence of raised neutralising antibody titres, with the detection of Coxsackie B specific IgM providing further evidence of recent infection. Herpes simplex was diagnosed in one patient by the presence of a rising complement fixation titre and isolation of the virus from the throat. Although this infection may have been coincidental or a local reactivation, an antibody rise of such magnitude is usually seen only in primary infection or in reactivation with systemic involvement. The presence of the virus in this setting was an unexpected finding as herpes simplex has not been previously described in association with myocarditis.
The occurrence of myocarditis during virus epidemics has been described previously,"I 12 and the patients in this study may represent part of such an epidemic. While up to 33% of patients with viral infections may develop some form of myocardial damage as a result,' 3 an unusual feature of our patients is that such a high proportion were young and presented with major haemodynamic complications of myocarditis. It was not possible to culture the virus from the myocardial tissue nor to detect specific viral antigens in the myocardium. Similar results have been reported by Takatsu et al. 14 These findings suggest that the virus is no longer present in the myocardium and this is supported by the experimental evidence of Wilson et al.'5 which showed the presence of myocarditis long after the virus had cleared from the tissues. The acute histological changes may therefore reflect an immune response, and indeed there is increasing evidence that autoimmune mechanisms may be implicated in the production of myocardial necrosis after viral infections. Cytotoxic T lymphocytes have been suggested as a cause of myocardial damage,'6 and furthermore the studies of Fowles et al. 17 indicated a defect in mononuclear cell suppressor activity in patients with congestive cardiomyopathy.
The concept of a persisting autoimmune process directed against the myocardium has suggested a role for immunosuppressive drugs in the treatment of myocarditis. Animal studies have indicated that this treatment might have a detrimental effect in the acute infective stage. '8 19 Such an effect, however, is unlikely in the clinical setting. As already stated, the virus does not appear to persist in the myocardium to the time of onset of treatment, and in this study the average time between the onset of symptoms and diagnosis was 11 weeks. There have been several reports of cases of myocarditis that have responded to treatment with corticosteroids and azathioprine.Y22 The experience quoted by Mason et al.2 also supports the role of immunosuppressive treatment in myocarditis.
We have investigated the effects of immunosuppressive treatment in a group of patients with moderate to severe myocardial dysfunction due to inflammatory myocarditis. A significant improvement in myocardial function was associated with histological evidence of healing in the first two months, and this was paralleled by an improvement in symptomatic state. But between 80% and 90% of patients with clinically diagnosed myocarditis recovered completely.23 Furthermore, there was some variability of response to treatment in our group of patients, particularly those on long term follow up. It is therefore difficult to be certain that the documented improvement relates to the effects of immunosuppressive treatment rather than reflecting the natural history of the disease in each patient. The clinical and histological relapse which followed cessation of immunosuppression in one patient with subsequent improvement on reinstatement of the treatment suggested a direct beneficial effect.
Endomyocardial biopsy played an important role in the management of these patients. Histological examination at the time of presentation allowed a definitive diagnosis of acute myocarditis to be made in all but one patient. In this patient the early negative biopsy, which was positive at six months, may have reflected a focal involvement of the myocardium.' Serial analysis of the histological features provided a detailed assessment of the state of the inflammatory process in the myocardium and so allowed more detailed monitoring of the course of the condition and the effect of immunosuppressive treatment. Serial biopsies in these patients also showed the presence of interstitial myocardial fibrosis, which may have important implications. It was noticeable that such fibrosis was most pronounced in those patients who despite the histological features of "healed myocarditis" progressed to a state of chronic congestive cardiac failure. Indeed, the histological examination of these patients at six months resembled the nonspecific changes of previous myocardial damage compatible with longstanding dilatation as previously described in congestive cardiomyopathy.24 A relation between preceding viral myocarditis and dilated cardiomyopathy has been suspected, and these findings indicate that the natural history of acute myocarditis may include progression to dilated cardiomyopathy. The question as to whether early intervention with immunosuppressive treatment will alter this progression has not been answered.
A need is clearly indicated for a multicentre randomised trial to establish the value of immunosuppressive treatment in histologically proved acute myocarditis and to document the natural history of this condition.
